Substances will not undergo further evaluation of health and safety risks at this time

Activists say contracts with companies violate federal law

The $4.9 billion deal adds a mid-stage cancer drug to the big biotech's pipeline

Product launches and champagne toasts at instrumentation conference bely worries about infection

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits

USDA delays some requirements for growers, FDA seeks more data on cannabidiol products

Congress opts for open-ended support for federal and local agencies

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Product launches and champagne toasts belied worries about infection

160-million-atom simulation reveals potential drug targets

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product

Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle

The MIT chemical engineering head is charting a course into the start-up world with LayerBio

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

C&EN looks at how scientists are adapting to travel restrictions and working from home

Spring lineup of conferences and events frequented by chemists is slashed

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe

Chemical makers brace for a slowdown on the continent

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking

Congress opts for open-ended support for federal and local agencies

C&EN looks at how scientists are working from home and adapting to travel restrictions

USDA delays some requirements for growers; FDA seeks more data on cannabidiol products

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery

Models predict an ‘alloy' of H and O is a metallic fluid in the ice giants' interior

Technique lets chemists control 3 variables independently and at micrometer resolution

Specialty chemical CEOs are rolling with the punches to keep their firms going

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost

Chemical makers and oil producers are pulling back on production, reconsidering investments

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists

Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

NO₂ levels have fallen sharply in northern Italy and China

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Current ACS Scholar Rebecca Leuschen chats with this University of Michigan professor about motivation

The US has a fraught history at the intersection of science and China relations

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

Chemistry CROs are back in business as rest of world starts to lock down

Only NIH, NSF publicize their complaint procedures

Italian workers threaten to strike, but German, UK companies and workers pull together

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

E-cigarettes deliver lead, arsenic, nickel, and other metals at harmful levels